Papillary thyroid cancer medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
{{familytree | | B01 | | | | | B02 | | | | | B03 |B01=Localized or regional [[tumor]]|B02=[[Metastatic]]|B03=Recurrent}} | {{familytree | | B01 | | | | | B02 | | | | | B03 |B01=Localized or regional [[tumor]]|B02=[[Metastatic]]|B03=Recurrent}} | ||
{{familytree | | |!| | | | | | |!| | | | | | |!| | }} | {{familytree | | |!| | | | | | |!| | | | | | |!| | }} | ||
{{familytree | | C01 | | | | | |!| | | | | C03 |C01=[[Surgery]]<br>Total [[thyroidectomy]]<br>Lobectomy<br>[[Radioactive iodine uptake|RAI therapy]]<br>Thyroid suppression therapy<br>[[External beam radiation therapy|EBRT]]|C03=[[Surgery]] ± postoperative [[Radioactive iodine uptake|RAI therapy]]<br>Targeted therapy<br>[[External beam radiation therapy|EBRT]]<br>[[Chemotherapy]]}} | {{familytree | | C01 | | | | | |!| | | | | | C03 |C01=[[Surgery]]<br>Total [[thyroidectomy]]<br>Lobectomy<br>[[Radioactive iodine uptake|RAI therapy]]<br>Thyroid suppression therapy<br>[[External beam radiation therapy|EBRT]]|C03=[[Surgery]] ± postoperative [[Radioactive iodine uptake|RAI therapy]]<br>Targeted therapy<br>[[External beam radiation therapy|EBRT]]<br>[[Chemotherapy]]}} | ||
{{familytree | | | | | | |,|-|-|^|-|-|.| | }} | {{familytree | | | | | | |,|-|-|^|-|-|.| | }} | ||
{{familytree | | | | | | D01 | | | | D03 | |D01=Iodine sensitive|D03=Iodine resistent}} | {{familytree | | | | | | D01 | | | | D03 | |D01=Iodine sensitive|D03=Iodine resistent}} | ||
Revision as of 18:58, 14 August 2019
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer medical therapy |
|
Risk calculators and risk factors for Papillary thyroid cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Ammu Susheela, M.D. [3]
Overview
Patients with papillary thyroid cancer are treated with radioactive iodine therapy, hormone therapy, and targeted medical therapy.
Medical Therapy
- Treatment options for papillary thyroid cancer include:[1]
| Papillary thyroid cnacer treatment | |||||||||||||||||||||||||||||||||||||
| Localized or regional tumor | Metastatic | Recurrent | |||||||||||||||||||||||||||||||||||
| Surgery Total thyroidectomy Lobectomy RAI therapy Thyroid suppression therapy EBRT | Surgery ± postoperative RAI therapy Targeted therapy EBRT Chemotherapy | ||||||||||||||||||||||||||||||||||||
| Iodine sensitive | Iodine resistent | ||||||||||||||||||||||||||||||||||||
| RAI therapy Thyroid suppression therapy | Thyroid suppression therapy Targeted therapy Surgery EBRT | ||||||||||||||||||||||||||||||||||||
| Papillary Thyroid Cancer Treatment Options |
|---|
Radiation Therapy
- External beam radiation therapy
- Intensity modulated radiation therapy
Precision Medicine and Targeted Therapy
- Sorafenib[2]
- Lenvatinib
Hormone Therapy
- Levothyroxine in a dosage of 2.5-3.5 mcg/kg/day is recommended for patients post thyroidectomy.
References
- ↑ "Thyroid Cancer Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute".
- ↑ Targetted therapy for thyroid cancer.Cancer.org(2015). http://www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-treating-targeted-therapy Accessed on November,4, 2015